Trials / Sponsors / Lipomedix Pharmaceuticals Inc.
Lipomedix Pharmaceuticals Inc.
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Promitil Treatment of Patients With Solid Tumors Associated With Deleterious Mutations Who Have Progressed Aft Cancer of Ovary, Pancreatic Ductal Adenocarcinoma | Phase 2 | 2024-06-13 |
| Terminated | Assessment of Safety and Therapeutic Efficacy of Promitil in Combination With Folfox in Patients With GI Malig Cancer, Gastro-Intestinal Intraepithelial Neoplasia | Phase 1 | 2021-01-13 |
| Completed | Intravenously Administered Liposomal PROMITIL in Combination With External Beam Radiotherapy in Cancer Patient Cancer, Solid Tumor, Metastatic Disease | Phase 1 | 2019-01-03 |
| Completed | Intravenously Administered Pegylated Liposomal Mitomycin-C Lipid-based Prodrug (PROMITIL) in Cancer Patients W Cancer, Solid Tumor, Metastatic Colorectal Cancer (mCRC) | Phase 1 | 2012-10-01 |